Our partners are advancing several compounds in clinical trials that were the outcome of previous drug discovery collaborations with Astex. The responsibility for developing these products is with our partners.
CDK4/6 inhibitor (Oncology)
Beta Secretase (BACE) inhibitor (Alzheimer’s disease)
PKB/Akt Inhibitor (Oncology)
FGFr inhibitor (Oncology)